Latest
Locals Mezzion Reports Positive In Vivo Results for Udenafil in ADPKD
Business Mezzion Pharma Co., Ltd.August 2, 2026 Seoul, Korea, Aug. 2, 2026 /PRNewswire/ -- Mezzion Pharma Co., Ltd. today announced positive results from a new in vivo study of udenafil, a novel phosphodiesterase type 5 (PDE5) inhibitor, in autosomal dominant...






